Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
International Journal of Clinical Oncology|January 8, 2025
The real-world efficacy and safety of frontline therapy of obinutuzumab plus bendamustine for untreated high-tumor-burden follicular lymphomaHiroaki Nagata, Taku Tsukamoto, Tsutomu Kobayashi, et al.
Cancer Science|December 5, 2023
miR-17-92 cluster-BTG2 axis regulates B-cell receptor signaling in mantle cell lymphomaYuka Kawaji-Kanayama, Taku Tsukamoto, Masakazu Nakano, et al.
Internal Medicine (Tokyo, Japan)|February 2, 2025
Primary Cutaneous CD8-positive Aggressive Epidermotropic Cytotoxic T-cell Lymphoma Complicated by Paraneoplastic EncephalitisYu Inoue, Taku Tsukamoto, Kentaro Mizuhara, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 2, 2025
[Clinical issues and perspectives in diffuse large B-cell lymphoma based on 15 years of clinical studies by the Kyoto Hematology Clinical Research Group (KOTOSG)]Eri Kawata, Takahiro Fujino, Tsutomu Kobayashi, et al.
The Journal of Biological Chemistry|December 24, 2002
Expression cloning and characterization of a novel glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein, GPI-HBP1Ryoichi X Ioka, Man-Jong Kang, Shin Kamiyama, et al.
Leukemia|February 17, 2025
Improved prognosis of advanced-stage extranodal NK/T-cell lymphoma: results of the NKEA-Next studyAyumi Fujimoto, Kana Miyazaki, Kimikazu Yakushijin, et al.
Infection and Drug Resistance|February 1, 2023
Impact of Treatment with Anti-CD20 Monoclonal Antibody on the Production of Neutralizing Antibody Against Anti-SARS-CoV-2 Vaccination in Mature B-Cell NeoplasmsAkio Onishi, Yayoi Matsumura-Kimoto, Shinsuke Mizutani, et al.
Cancer Medicine|September 13, 2022
Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa-associated lymphoid tissue lymphoma: A retrospective studyKentaro Mizuhara, Tsutomu Kobayashi, Mitsushige Nakao, et al.
The Journal of Biological Chemistry|February 13, 2004
A Kruppel-like factor KLF15 contributes fasting-induced transcriptional activation of mitochondrial acetyl-CoA synthetase gene AceCS2Joji Yamamoto, Yukio Ikeda, Haruhisa Iguchi, et al.
International Journal of Hematology|June 28, 2023
Real-world practice-based prognostic model for higher-risk myelodysplastic syndromes treated with azacitidine monotherapy: The Kyoto prognostic scoring systemHaruya Okamoto, Yu Inoue, Akihiro Miyashita, et al.
Pageof 8